Unichem Laboratories Ltd. benchmarking: Perfomance to industry peers

Financial

	Unichem Lab	Bliss GVS Pharma	Novartis
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	41.0 .	n/a	n/a
Number of ANDA's Approved By USFDA	27.0 .	n/a	n/a
R&D as a % of Total Sales	5.35 %	2.7 %	n/a
Financials
5 yr Average ROE	1.64 %	6.83 %	8.11 %
5yr average Equity Multiplier	1.32	1.3	2.72
5yr Average Asset Turnover Ratio	0.47	0.62	0.18
5yr Avg Net Profit Margin	-1.68 %	8.7 %	17.12 %
Price to Book	0.91	1.97	2.98
P/E	7.47	20.45	23.72
5yr Avg Cash Conversion Cycle	88.84 Days	186.56 Days	-23.33 Days
Inventory Days	151.32 Days	54.35 Days	44.27 Days
Days Receivable	122.86 Days	189.93 Days	38.18 Days
Days Payable	205.05 Days	75.78 Days	124.28 Days
5yr Average Interest Coverage Ratio	2.41	14.68	65.43
5yr Avg ROCE	1.04 %	13.27 %	5.91 %
5yr Avg Operating Profit Margin	5.43 %	17.03 %	15.15 %
5 yr average Debt to Equity	0.11	0.11	0.0
5yr CAGR Net Profit	32.0 %	4.24 %	37.01 %
5yr Average Return on Assets	-0.65 %	5.31 %	3.13 %
Shareholdings
Promoter Holding	70.22 %	35.36 %	70.68 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	19.29 %	0.9 %	0.0
Change in Mutual Fund Holding (3 Yrs)	2.39 %	0.0	0.0

	Unichem Lab	Bliss GVS Pharma	Novartis
Product Wise Break-Up	Product Wise Break-Up Formulations 92.3 Bulk Chemicals 7.7 Anti Inflammatory 0 Anti-biotic 0 Anti-bacterial 0 Anti-fungal, 0 Antimalarial 0 0	Product Wise Break-Up Anti Malarials 43.0 Antibiotics 5.0 Bulk Chemicals 0 Anti Inflammatory 7.0 0 Formulations 0 Anti-bacterial 0 Anti-fungal 16.0 Others 29.0	Product Wise Break-Up Antimalarial 0 Anti-biotic 0 Bulk Chemicals 0 Anti Inflammatory 0 Wholesale of pharmaceuticals and medical goods 100.0 Formulations 0 Anti-bacterial 0 Anti-fungal, 0
Location Wise Break-Up	Location Wise Break-Up USA 64.2 India 1.97 Rest of the World 0 Others 33.83	Location Wise Break-Up India 6.61 Rest of the World 93.39 USA 0	Location Wise Break-Up India 100.0 Rest of the World 0 USA 0